Anixa Biosciences, Inc.
ANIX · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,280 | -$2,813 | -$3,213 | -$2,913 |
| Dep. & Amort. | $168 | $9 | -$243 | $9 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $829 | $962 | $1,031 | $980 |
| Change in WC | $363 | $140 | -$503 | $973 |
| Other Non-Cash | -$591 | $199 | $24 | $24 |
| Operating Cash Flow | -$1,511 | -$1,503 | -$2,904 | -$927 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $11,932 | -$11,932 | $0 | -$16,463 |
| Inv. Sales/Matur. | $10,938 | $14,274 | $15,700 | $17,330 |
| Other Inv. Act. | -$23,703 | $0 | -$12,997 | $0 |
| Investing Cash Flow | -$833 | $2,342 | $2,703 | $867 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,924 | $4 | $0 | -$29 |
| Stock Repurch. | $0 | $14 | $0 | -$33 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,929 | $4 | -$17 | $141 |
| Financing Cash Flow | $1,929 | $18 | -$17 | $106 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$415 | $857 | -$218 | $46 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,910 | $1,053 | $1,271 | $1,225 |
| End Cash | $1,495 | $1,910 | $1,053 | $1,271 |
| Free Cash Flow | -$1,511 | -$1,503 | -$2,904 | -$927 |